Answer to Question 1
Correct Answer: 2,5
Rationale 1: This response does not answer the client's question.
Rationale 2: Darbepoetin alfa (Aranesp) is an erythropoiesis-stimulating factor.
Rationale 3: Darbepoetin alfa (Aranesp) does not increase immunity.
Rationale 4: The nurse should explain the medication in terms the client can understand.
Rationale 5: Darbepoetin alfa (Aranesp) stimulates production of red blood cells which carry oxygen. Getting additional oxygen to the tissues helps the client feel better.
Answer to Question 2
Correct Answer: 1,2,4
Rationale 1: The purpose of this therapy is to increase red blood cells which would increase hemoglobin.
Rationale 2: Since the client has more RBCs, more oxygen can be carried to tissues.
Rationale 3: This drug supports RBC production, not platelet production.
Rationale 4: Increase in activity level indicates treatment success.
Rationale 5: This treatment supports red blood cell production, not white blood cell production.
The nurse uses a noninvasive bladder ultrasound to measure the client’s bladder volume.
Use a step stool to help an infirm client get on and off the table.
NCC MERP Index for categorizing medication errors algorithm.
The injectors receive fuel and are supported by the fuel rail.
Client files are kept in alphabetical order in locked file cabinets.
Distribution of sex chromosomes from generation to generation. All children receive an X chromosome